We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Partnerre Ltd. | NYSE:PRE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 140.52 | 0 | 01:00:00 |
From May 2019 to May 2024
Piramal Healthcare Ltd. (500302.BY) is planning to invest at least $1.5 billion to buy biotech companies and patents and enter ventures with pharmaceutical groups to develop new drugs, the Financial Times reported late Sunday, citing an interview with chairman Ajay Piramal.
Piramal has already been talking to a number of big pharmaceutical groups in U.S. and Europe, but he declined to name the groups involved, the FT said on its website. Piramal, however, said that he hoped to announce the first major deal within the next six to 12 months, according to FT.
Full Story: http://www.ft.com/intl/cms/s/0/d8997a7c-cdaf-11e0-bb4f-00144feabdc0.html#axzz1WNDtIJ8r
1 Year Partnerre Chart |
1 Month Partnerre Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
